Ligand validation:8RT3

DO3: 10-((2R)-2-HYDROXYPROPYL)-1,4,7,10-TETRAAZACYCLODODECANE 1,4,7-TRIACETIC ACID

DO3 is a Ligand Of Interest in 8RT3 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8RT3_DO3_A_1004	32%	39%	0.263	0.937	1.12	1.28	1	4	3	0	100%	0.68
8RT3_DO3_A_1002	4%	53%	0.295	0.679	0.72	1.07	1	1	0	0	100%	0.66
4TWS_DO3_A_204	63%	36%	0.147	0.942	1.31	1.23	2	2	0	0	100%	0.57
8RT2_DO3_A_1004	55%	49%	0.134	0.902	0.84	1.13	1	4	1	0	100%	0.73
6SR4_DO3_A_203	41%	74%	0.235	0.953	0.37	0.64	-	-	1	0	100%	1
8A9E_DO3_AAA_203	38%	59%	0.146	0.848	0.81	0.76	1	-	2	0	100%	0.81
6SR5_DO3_A_203	33%	67%	0.237	0.917	0.51	0.74	-	1	1	0	100%	1
2QMI_DO3_G_451	53%	29%	0.156	0.917	1.42	1.4	6	5	0	0	100%	0.71
5NPL_DO3_A_302	44%	21%	0.236	0.965	1.17	2.09	1	14	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.